nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—SLC22A11—Methotrexate—systemic lupus erythematosus	0.11	0.193	CbGbCtD
Doxycycline—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.084	0.148	CbGbCtD
Doxycycline—MMP13—synovial fluid—systemic lupus erythematosus	0.0674	0.238	CbGeAlD
Doxycycline—SLC22A8—Methotrexate—systemic lupus erythematosus	0.0638	0.112	CbGbCtD
Doxycycline—MMP1—synovial fluid—systemic lupus erythematosus	0.0474	0.168	CbGeAlD
Doxycycline—SLC22A6—Methotrexate—systemic lupus erythematosus	0.0445	0.0781	CbGbCtD
Doxycycline—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0391	0.0686	CbGbCtD
Doxycycline—CYP3A4—Dapsone—systemic lupus erythematosus	0.0341	0.0599	CbGbCtD
Doxycycline—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0296	0.052	CbGbCtD
Doxycycline—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0296	0.052	CbGbCtD
Doxycycline—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0254	0.0446	CbGbCtD
Doxycycline—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0251	0.044	CbGbCtD
Doxycycline—SLC22A8—choroid plexus—systemic lupus erythematosus	0.0247	0.0873	CbGeAlD
Doxycycline—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0238	0.0417	CbGbCtD
Doxycycline—CYP3A4—Prednisone—systemic lupus erythematosus	0.0237	0.0415	CbGbCtD
Doxycycline—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0224	0.0394	CbGbCtD
Doxycycline—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0148	0.0259	CbGbCtD
Doxycycline—MMP8—blood plasma—systemic lupus erythematosus	0.0124	0.0437	CbGeAlD
Doxycycline—MMP1—endothelium—systemic lupus erythematosus	0.0108	0.0384	CbGeAlD
Doxycycline—MMP13—connective tissue—systemic lupus erythematosus	0.0073	0.0258	CbGeAlD
Doxycycline—SLC22A8—urine—systemic lupus erythematosus	0.00661	0.0234	CbGeAlD
Doxycycline—MMP8—connective tissue—systemic lupus erythematosus	0.00658	0.0233	CbGeAlD
Doxycycline—MMP7—connective tissue—systemic lupus erythematosus	0.00581	0.0206	CbGeAlD
Doxycycline—MMP7—nephron tubule—systemic lupus erythematosus	0.00563	0.0199	CbGeAlD
Doxycycline—MMP1—connective tissue—systemic lupus erythematosus	0.00513	0.0181	CbGeAlD
Doxycycline—MMP13—tendon—systemic lupus erythematosus	0.00501	0.0177	CbGeAlD
Doxycycline—MMP7—kidney—systemic lupus erythematosus	0.00495	0.0175	CbGeAlD
Doxycycline—MMP7—cortex of kidney—systemic lupus erythematosus	0.00482	0.017	CbGeAlD
Doxycycline—MMP8—lymphoid tissue—systemic lupus erythematosus	0.00481	0.017	CbGeAlD
Doxycycline—MMP1—skin of body—systemic lupus erythematosus	0.00463	0.0164	CbGeAlD
Doxycycline—MMP13—lung—systemic lupus erythematosus	0.0044	0.0156	CbGeAlD
Doxycycline—MMP8—bone marrow—systemic lupus erythematosus	0.00438	0.0155	CbGeAlD
Doxycycline—MMP7—lymphoid tissue—systemic lupus erythematosus	0.00425	0.015	CbGeAlD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGAM—systemic lupus erythematosus	0.00402	0.0286	CbGpPWpGaD
Doxycycline—MMP8—lung—systemic lupus erythematosus	0.00397	0.014	CbGeAlD
Doxycycline—MMP1—lymphoid tissue—systemic lupus erythematosus	0.00375	0.0133	CbGeAlD
Doxycycline—MMP1—tendon—systemic lupus erythematosus	0.00353	0.0125	CbGeAlD
Doxycycline—MMP7—lung—systemic lupus erythematosus	0.00351	0.0124	CbGeAlD
Doxycycline—CYP3A4—urine—systemic lupus erythematosus	0.00327	0.0116	CbGeAlD
Doxycycline—SLC22A11—nephron tubule—systemic lupus erythematosus	0.00315	0.0111	CbGeAlD
Doxycycline—MMP1—lung—systemic lupus erythematosus	0.00309	0.0109	CbGeAlD
Doxycycline—SLC22A6—nephron tubule—systemic lupus erythematosus	0.00297	0.0105	CbGeAlD
Doxycycline—SLC22A11—kidney—systemic lupus erythematosus	0.00277	0.0098	CbGeAlD
Doxycycline—SLC22A11—cortex of kidney—systemic lupus erythematosus	0.0027	0.00954	CbGeAlD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUNB—systemic lupus erythematosus	0.00262	0.0186	CbGpPWpGaD
Doxycycline—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.00254	0.00899	CbGeAlD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—F2—systemic lupus erythematosus	0.00247	0.0176	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—RASGRP3—systemic lupus erythematosus	0.00243	0.0173	CbGpPWpGaD
Doxycycline—Minocycline—VEGFA—systemic lupus erythematosus	0.00232	0.331	CrCbGaD
Doxycycline—Minocycline—MMP9—systemic lupus erythematosus	0.00224	0.32	CrCbGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—systemic lupus erythematosus	0.00223	0.0159	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—JUNB—systemic lupus erythematosus	0.00217	0.0154	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.0021	0.0149	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—ITGAX—systemic lupus erythematosus	0.00209	0.0149	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.002	0.0142	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—ETS1—systemic lupus erythematosus	0.00196	0.0139	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—SELE—systemic lupus erythematosus	0.00193	0.0137	CbGpPWpGaD
Doxycycline—SLC22A8—nephron tubule—systemic lupus erythematosus	0.00178	0.00629	CbGeAlD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	0.00176	0.0125	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP9—systemic lupus erythematosus	0.00174	0.0124	CbGpPWpGaD
Doxycycline—CYP3A4—blood plasma—systemic lupus erythematosus	0.00171	0.00604	CbGeAlD
Doxycycline—Methacycline—ALB—systemic lupus erythematosus	0.0017	0.243	CrCbGaD
Doxycycline—MMP8—Extracellular matrix organization—ITGAX—systemic lupus erythematosus	0.0017	0.0121	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—JAK1—systemic lupus erythematosus	0.00168	0.012	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—JUNB—systemic lupus erythematosus	0.00167	0.0119	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—SELE—systemic lupus erythematosus	0.00166	0.0118	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TNF—systemic lupus erythematosus	0.00162	0.0115	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—JAK1—systemic lupus erythematosus	0.0016	0.0113	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—JUNB—systemic lupus erythematosus	0.00158	0.0112	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—ITGAM—systemic lupus erythematosus	0.00156	0.0111	CbGpPWpGaD
Doxycycline—SLC22A8—kidney—systemic lupus erythematosus	0.00156	0.00553	CbGeAlD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.00153	0.0109	CbGpPWpGaD
Doxycycline—SLC22A8—cortex of kidney—systemic lupus erythematosus	0.00152	0.00538	CbGeAlD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—LYN—systemic lupus erythematosus	0.00151	0.0107	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.00148	0.0105	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.00146	0.0104	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.00141	0.01	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic lupus erythematosus	0.0014	0.00995	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—FOXP3—systemic lupus erythematosus	0.00137	0.00972	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—PRL—systemic lupus erythematosus	0.00128	0.00909	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—systemic lupus erythematosus	0.00127	0.00902	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ITGAM—systemic lupus erythematosus	0.00127	0.009	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic lupus erythematosus	0.00125	0.00887	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ITGAX—systemic lupus erythematosus	0.00124	0.00879	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—JAK1—systemic lupus erythematosus	0.00123	0.00875	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—systemic lupus erythematosus	0.00123	0.00871	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—systemic lupus erythematosus	0.00123	0.00871	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL10—systemic lupus erythematosus	0.00122	0.00864	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ITGAX—systemic lupus erythematosus	0.0012	0.00849	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.00118	0.00842	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL4—systemic lupus erythematosus	0.00118	0.00841	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—systemic lupus erythematosus	0.00118	0.00839	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—ETS1—systemic lupus erythematosus	0.00118	0.00837	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—systemic lupus erythematosus	0.00117	0.00833	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CCL2—systemic lupus erythematosus	0.00116	0.00821	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN1A—systemic lupus erythematosus	0.00115	0.00817	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—systemic lupus erythematosus	0.00114	0.0081	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—NR3C1—systemic lupus erythematosus	0.00113	0.008	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—systemic lupus erythematosus	0.00113	0.00799	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.00111	0.0079	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TYK2—systemic lupus erythematosus	0.00105	0.00746	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL4—systemic lupus erythematosus	0.00104	0.00741	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—VEGFA—systemic lupus erythematosus	0.00104	0.00736	CbGpPWpGaD
Doxycycline—SLC22A8—nervous system—systemic lupus erythematosus	0.00103	0.00363	CbGeAlD
Doxycycline—MMP13—AGE/RAGE pathway—NOS3—systemic lupus erythematosus	0.00102	0.00723	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—TGFB1—systemic lupus erythematosus	0.00101	0.00718	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic lupus erythematosus	0.001	0.00712	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—NR3C1—systemic lupus erythematosus	0.000992	0.00704	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—systemic lupus erythematosus	0.000988	0.00702	CbGpPWpGaD
Doxycycline—SLC22A8—central nervous system—systemic lupus erythematosus	0.000987	0.00349	CbGeAlD
Doxycycline—MMP7—AGE/RAGE pathway—NOS3—systemic lupus erythematosus	0.000983	0.00698	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—systemic lupus erythematosus	0.000981	0.00697	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—systemic lupus erythematosus	0.000981	0.00697	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—systemic lupus erythematosus	0.000966	0.00686	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ITGAX—systemic lupus erythematosus	0.000955	0.00679	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—systemic lupus erythematosus	0.000954	0.00678	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—systemic lupus erythematosus	0.00095	0.00675	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—JUNB—systemic lupus erythematosus	0.000948	0.00674	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN1B—systemic lupus erythematosus	0.000942	0.00669	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ITGAM—systemic lupus erythematosus	0.000924	0.00657	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—systemic lupus erythematosus	0.000912	0.00648	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000903	0.00642	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ITGAM—systemic lupus erythematosus	0.000893	0.00634	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CDKN1B—systemic lupus erythematosus	0.000893	0.00634	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CCL2—systemic lupus erythematosus	0.000893	0.00634	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—systemic lupus erythematosus	0.000881	0.00626	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN1A—systemic lupus erythematosus	0.000869	0.00617	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000848	0.00602	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCL2—systemic lupus erythematosus	0.000841	0.00598	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—systemic lupus erythematosus	0.000837	0.00595	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—systemic lupus erythematosus	0.000817	0.0058	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TYK2—systemic lupus erythematosus	0.000811	0.00576	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—TGFB1—systemic lupus erythematosus	0.000808	0.00574	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—systemic lupus erythematosus	0.000789	0.0056	CbGpPWpGaD
Doxycycline—CYP3A4—kidney—systemic lupus erythematosus	0.000774	0.00274	CbGeAlD
Doxycycline—MMP13—Endochondral Ossification—VEGFA—systemic lupus erythematosus	0.000752	0.00534	CbGpPWpGaD
Doxycycline—Tetracycline—ALB—systemic lupus erythematosus	0.000747	0.106	CrCbGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—VEGFA—systemic lupus erythematosus	0.000742	0.00527	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IFNG—systemic lupus erythematosus	0.000715	0.00508	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—F2—systemic lupus erythematosus	0.000715	0.00508	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ITGAM—systemic lupus erythematosus	0.000714	0.00507	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000708	0.00503	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB1—systemic lupus erythematosus	0.00069	0.0049	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CDKN1B—systemic lupus erythematosus	0.000689	0.0049	CbGpPWpGaD
Doxycycline—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000685	0.00487	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—systemic lupus erythematosus	0.000673	0.00478	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—systemic lupus erythematosus	0.00065	0.00462	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN1B—systemic lupus erythematosus	0.00065	0.00461	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—systemic lupus erythematosus	0.000643	0.00457	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL2—systemic lupus erythematosus	0.000636	0.00452	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IFNG—systemic lupus erythematosus	0.00063	0.00448	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	0.000628	0.00446	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—systemic lupus erythematosus	0.000622	0.00442	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—systemic lupus erythematosus	0.000621	0.00441	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—systemic lupus erythematosus	0.000602	0.00427	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—systemic lupus erythematosus	0.000573	0.00407	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—EP300—systemic lupus erythematosus	0.00057	0.00405	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ITGAX—systemic lupus erythematosus	0.000568	0.00403	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000565	0.00401	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL2—systemic lupus erythematosus	0.00056	0.00398	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—F3—systemic lupus erythematosus	0.00056	0.00398	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CDKN1A—systemic lupus erythematosus	0.000528	0.00375	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—EP300—systemic lupus erythematosus	0.000528	0.00375	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000525	0.00373	CbGpPWpGaD
Doxycycline—CYP3A4—nervous system—systemic lupus erythematosus	0.000508	0.0018	CbGeAlD
Doxycycline—MMP1—Hemostasis—CLU—systemic lupus erythematosus	0.000506	0.00359	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—EP300—systemic lupus erythematosus	0.000503	0.00357	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—systemic lupus erythematosus	0.000496	0.00353	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	0.000496	0.00352	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—P2RY12—systemic lupus erythematosus	0.00049	0.00348	CbGpPWpGaD
Doxycycline—CYP3A4—central nervous system—systemic lupus erythematosus	0.000489	0.00173	CbGeAlD
Doxycycline—MMP1—Hemostasis—SELE—systemic lupus erythematosus	0.000451	0.0032	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CSK—systemic lupus erythematosus	0.000451	0.0032	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000431	0.00306	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ITGAM—systemic lupus erythematosus	0.000424	0.00301	CbGpPWpGaD
Doxycycline—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.00041	0.00291	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—LYN—systemic lupus erythematosus	0.00041	0.00291	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000406	0.00288	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SH2B3—systemic lupus erythematosus	0.000402	0.00286	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	0.000374	0.00265	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—systemic lupus erythematosus	0.000369	0.00262	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CDKN1A—systemic lupus erythematosus	0.000361	0.00256	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.00036	0.00256	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—EP300—systemic lupus erythematosus	0.000343	0.00244	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL6—systemic lupus erythematosus	0.000329	0.00234	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IFNA1—systemic lupus erythematosus	0.000316	0.00224	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	0.000308	0.00219	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000308	0.00218	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	0.000304	0.00216	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFB1—systemic lupus erythematosus	0.000298	0.00212	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000292	0.00207	CbGpPWpGaD
Doxycycline—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.00027	0.00192	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—systemic lupus erythematosus	0.000269	0.00191	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACE—systemic lupus erythematosus	0.00026	0.00185	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—systemic lupus erythematosus	0.00026	0.00185	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—JAK1—systemic lupus erythematosus	0.000239	0.00169	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000233	0.00166	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IL2RA—systemic lupus erythematosus	0.000223	0.00158	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	0.000222	0.00158	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	0.000214	0.00152	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—systemic lupus erythematosus	0.000208	0.00148	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—F2—systemic lupus erythematosus	0.000194	0.00138	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—systemic lupus erythematosus	0.000171	0.00122	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000163	0.00116	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000162	0.00115	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ALB—systemic lupus erythematosus	0.000161	0.00114	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000161	0.00114	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS3—systemic lupus erythematosus	0.000154	0.00109	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—F2—systemic lupus erythematosus	0.000153	0.00108	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000144	0.00102	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CCL2—systemic lupus erythematosus	0.000136	0.000966	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000132	0.000941	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IL2—systemic lupus erythematosus	0.000131	0.000928	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	0.000126	0.000892	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000124	0.000879	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000123	0.000871	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—EP300—systemic lupus erythematosus	0.000117	0.000832	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—systemic lupus erythematosus	0.000111	0.000788	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.00011	0.000779	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000102	0.000727	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—systemic lupus erythematosus	0.000102	0.000724	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.15e-05	0.00065	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.17e-05	0.00058	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	7.04e-05	0.0005	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.23e-05	0.000442	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.2e-05	0.000369	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	2.15e-05	0.000152	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.2e-05	8.55e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	7.6e-06	5.4e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	6.83e-06	4.85e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	6.53e-06	4.64e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	5.98e-06	4.25e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	4.97e-06	3.53e-05	CbGpPWpGaD
